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Background: We evaluated the efficacy of multilocus sequence typing (MLST) for assessing the genetic relationship among Candi-
da albicans isolates from patients with candidemia in a hospital setting.
Methods: A total of 45 C. albicans isolates from 21 patients with candidemia were analyzed. The MLST results were compared with 
results obtained by Southern blot hybridization (C1 fingerprinting) and pulsed-field gel electrophoresis (PFGE). PFGE analysis in-
cluded karyotyping and restriction endonuclease analysis of genomic DNAs using BssHII (REAG-B) and SfiI (REAG-S).
Results: The 45 isolates yielded 20 unique diploid sequence types (DSTs) by MLST, as well as 12 karyotypes, 15 REAG-B patterns, 13 
REAG-S patterns, and 14 C1 fingerprinting types. Microevolution among intra-individual isolates was detected in 6, 5, 3, 5, and 7 
sets of isolates by MLST (1 or 2 allelic differences), REAG-B, REAG-S, C1 fingerprinting, and a combination of all methods, respective-
ly. Among 20 DSTs, 17 were unique, and 3 were found in more than 1 patient. The results of 2 DSTs obtained from 9 patient isolates 
were in agreement with REAG and C1 fingerprinting patterns. However, the remaining DST, which was shared by 2 patient isolates, 
showed 2 different PFGE and C1 fingerprinting patterns. In addition, 3 sets of isolates from different patients, which differed in only 
1 or 2 alleles by MLST, also exhibited different PFGE or C1 fingerprinting patterns.
Conclusions: MLST is highly discriminating among C. albicans isolates, but it may have some limitations in typing isolates from dif-
ferent patients, which may necessitate additional analysis using other techniques.
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INTRODUCTION
Candida albicans is the most common species causing 
Candida bloodstream infections (BSI). Nosocomial C. albi-
cans BSI develop primarily as a consequence of endogenous 
colonization, but are often caused by a strain acquired in 
hospital settings [1, 2]. Therefore, to identify the source of 
BSI caused by C. albicans, a suitable strain typing method is 
essential. In recent years, genomic microevolution (also 
called microvariation) has been documented for multiple C. 
albicans isolates from blood and other anatomic sites in in-
dividual patients with Candida BSI [1, 3-6]. Pfaller et al. [5] 
demonstrated that C. albicans BSI strains that are endemic 
in some hospitals undergo microevolution in the hospital 
setting. Given the rapid and frequent occurrence of C. albi-
cans microevolution, assessing genetic relatedness among C. 
albicans isolates from patients with BSI is particularly im-
portant for understanding and controlling nosocomial C. 
albicans BSI within hospitals.
Multilocus sequence typing (MLST), which is based on 
DNA sequence analysis of nucleotide polymorphisms within 
housekeeping gene fragments, is a reliable, objective, and 
highly discriminating molecular typing method for the char-
acterization of clinical C. albicans isolates [6, 7]. In addition, 
MLST permits the exchange of molecular typing data via the 
internet, which facilitates both local and global epidemio-
logic studies [7, 8]. To date, simultaneous comparisons of 108     www.kjlm.org
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pulsed-field gel electrophoresis (PFGE), Southern blot hy-
bridization, and MLST methods for genotyping C. albicans 
isolates from BSI patients has not been performed.
By using the MLST method, we analyzed the genetic rela-
tionships among C. albicans isolates from blood cultures 
and other anatomical sites from 21 patients with candidemia 
admitted to the same hospital over a 3-yr period. The pur-
pose of this study was to evaluate the usefulness of MLST 
relative to PFGE and Southern blot hybridization finger-
printing tools for detecting nosocomial clusters vs. micro-
evolution among C. albicans isolates from patients with C. 
albicans BSI.
 
MATERIALS AND METHODS
1. Patients and microorganisms
A total of 45 C. albicans isolates from 21 patients with 
candidemia were selected for this study. All isolates were 
obtained at Chonnam National University Hospital between 
September 1999 and August 2002. Previously described C. 
albicans strains from 2 nosocomial clusters of central ve-
nous catheter-related BSI (patients 15-21) were included in 
this study [3]. A single blood isolate was obtained from 10 
patients, but multiple isolates (2-7) were obtained from 11 
patients. C. albicans isolates were collected from cultures of 
clinical specimens before, during, or after collecting the iso-
lates that caused candidemia. The interval between C. albi-
cans isolation from blood culture and another body sites 
ranged between 1 and 32 days. Overall, isolates were cul-
tured from blood (25 isolates from 21 patients), catheter 
tips (9 isolates from 7 patients), respiratory specimens (6 
isolates from 3 patients), tissues (3 isolates from 1 patient), 
and urine (2 isolates from 2 patients). Species identification 
was based on colony morphology on CHROMagar Candida 
(BBL, Becton Dickinson, Sparks, MD, USA) at 35˚C, micro-
scopic morphology on cornmeal-Tween 80 agar, and use of 
a commercial system (API 20C; bioMérieux, Marcy L’Etoile, 
France, or the Vitek 2 system; Vitek 2 ID-YST, bioMérieux). 
We used the C. albicans strain, ATCC 20098, as a control in 
this study.
 
2. Multilocus sequence typing
C. albicans isolates were genotyped using the original 
MLST scheme described previously by Bougnoux et al. [6]. 
The internal regions of 7 housekeeping genes (AAT1a, 
ACC1, ADP1, MPIb, SYA1, VPS13, and ZWF1b) were se-
quenced. Sequence analysis was performed on both strands 
using an ABI Prism 3130xl Genetic Analyzer (Applied Bio-
systems, Foster City, CA, USA). Each strain was character-
ized by diploid sequence types (DSTs) resulting from the 
combination of genotypes obtained at 7 loci. Each strain 
was introduced into the original MLST online database 
(http://calbicans.mlst.net), which allowed us to compare 
these strains to those previously genotyped by this method 
and stored in the database.
3. Pulsed-field gel electrophoresis analysis
PFGE genotyping consisted of electrophoretic karyotyp-
ing and restriction endonuclease analysis of genomic DNA 
(REAG) using BssHII (REAG-B) and SfiI (REAG-S). PFGE 
methods for DNA preparation, REAG digestion, and elec-
trophoresis have been presented in detail previously [3]. 
Isolates that differed by 1 or more bands were considered to 
have different karyotypes. To analyze the REAG patterns, 
isolates differing by 1 or more bands were designated as be-
ing different types. However, the strains with banding pat-
terns that differed by 3 or fewer bands were described as 
subtypes (a or b) of a given clonal type. Serial isolates from 
the same patient showing a minor genotypic change (sub-
type) in the REAG pattern were said to have undergone mi-
croevolution.
4. Southern hybridization using the C1 fragment of the Ca3
    probe
Southern blot hybridization using the 0.98-kb C1 frag-
ment of Ca3 as a probe (C1 fingerprinting) was performed 
as previously described [3, 4]. Briefly, cells from single 
clonal colonies were transferred to YPD broth (1% yeast ex-
tract, 2% Bacto Peptone, 2% glucose; Difco, Detroit, MI, 
USA) and grown to the late log phase. DNA from each iso-
late was prepared using the method of Scherer and Stevens 
[9], digested with EcoRI, and separated on 0.8% agarose 
gels. Gels were stained with ethidium bromide to assess 
loading and transferred to nitrocellulose membranes. DNA 
fragments on the membranes were then hybridized with the 
radiolabeled C1 probe, as previously described [3, 4]. Blots 
were exposed to XAR-S film (Eastman Kodak Co., Roches-
ter, NY, USA). Autoradiographs were examined visually to 
assess both band position and band intensity. Isolates deter-
mined to differ by 1 or more bands were designated as be-
ing a different type. C. albicans isolates from the same pa-
tient or the same clone showed genetic variation (i.e., 1 or 2 
band differences), suggestive of microevolution [3, 4].
 
RESULTS
1. Sequence variability by MLST
A total of 2,883 bp from 7 housekeeping genes (AAT1a, Myoung Y, et al.  •  MLST for Candida albicans
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ACC1, ADP1, MPIb, SYA1, VPS13, and ZWF1b) were se-
quenced in each of the 45 isolates from 21 patients with 
candidemia. Sixty-nine (2.4%) nucleotide sites were poly-
morphic (Table 1). There were 7 polymorphic sites per gene 
in the AAT1a and ACC1 loci, 9 in the SYA1 locus, 10 in the 
ZWF1b locus, 11 in the ADP1 locus, 12 in the VPS13 locus, 
and 13 in the MPIb locus. Thirty-one (44.9%) of the 69 in-
dividual changes were non-synonymous. The 7 housekeep-
ing gene fragments sequenced displayed  8-10 different gen-
otypes. The ACC1 (1), ADP1 (1), and SYA1 (2) fragments 
generated 4 new genotypes.
A total of 20 unique DSTs were obtained from a combi-
nation of genotypes from 7 housekeeping genes for the 45 
clinical isolates. Twenty-three isolates from 14 patients be-
longed to previously described types (DSTs 90, 365, 656, 
659, 601, 602, 693, 1395, 1646, and 1711), whereas 22 iso-
lates from 12 patients belonged to new sequence types. Ten 
DSTs (DSTs 1788 to 1797) from our Korean strain collec-
tion novel to the internet DST database were added to the 
MLST database (http://calbicans.mlst.net).
2. Comparison of isolates from the same patient
In Table 2, the sequence of isolates, their anatomic sites, 
the date of isolation, and PFGE, C1 fingerprinting, and 
MLST types are presented for 45 isolates from each of the 
21 patients. Two or more C. albicans isolates from blood 
cultures and other anatomic sites were obtained for 11 pa-
tients (patients 1-7, 9, 11, 16, and 18). In each of the 11 can-
didemic patients, C. albicans recovered from other sites and 
C. albicans recovered from blood showed identical or simi-
lar MLST, PFGE, and C1 fingerprinting types, except for the 
respiratory isolates from patient 2. Two respiratory isolates 
(isolates 2-3 and 2-4) from patient 2 showed different geno-
type patterns from blood isolates by all methods (Fig. 1).
When serial isolates from the same patient were exam-
ined using a combination of MLST, PFGE, and C1 finger-
printing methods, a total of 7 sets of intra-individual isolates 
showed microevolution. Catheter isolates from 4 patients 
(patients 1, 2, 9, and 18) and respiratory isolates from 2 pa-
tients (patients 6 and 11) exhibited microevolution relative 
to blood isolates. In addition, respiratory isolates from 1 pa-
tient (isolates 2-3 and 2-4) had also undergone microevolu-
tion. Of 7 sets of isolates, 6 gave non-identical sequencing 
results for 1 or 2 of the test allele loci analyzed with MLST. 
Each of these 7 sets of isolates had the same karyotype. Mi-
croevolution among intra-individual isolates was detected 
by REAG-B (5 sets), REAG-S (2 sets), and C1 fingerprinting 
(5 sets).
3. Comparison among isolates from different patients
PFGE analysis revealed 12 different karyotypes, 15 differ-
ent REAG-B patterns, and 13 different REAG-S patterns 
among the isolates, whereas C1 fingerprinting identified 14 
different types (Table 2). Of the 20 DSTs, 17 were unique for 
each patient, whereas 3 were found in more than 1 patient. 
Of 3 DSTs, 2 (DSTs 1711 and 1792) were shared by isolates 
from a previously well-characterized set of 2 nosocomial 
clusters. These 2 DSTs were shared by isolates from 9 pedi-
atric patients (patients 13 to 21) admitted to the same inten-
sive care unit. MLST results of blood isolates from these 9 
patients were exactly matched by results from both PFGE 
(karyotyping, REAG-B, and REAG-S) and C1 fingerprint-
ing. The remaining DST (DST 365) was shared by isolates 
from 2 different patients (4 isolates from patient 7 and iso-
late 2-4 from patient 2). Even though they were assigned to 
DST 365, each patient’s isolates showed different PFGE and 
C1 fingerprinting patterns.
When the MLST sequence results from different patients 
were examined, 3 sets of isolates were found to have only 1 
or 2 allelic differences (closely related). Of 3 sets, 1 set of 
isolates (isolate 8-1 and the isolates from patient 7) had 
similar C1 fingerprinting patterns, but different karyotyp-
ing and REAG patterns. In addition, 2 other sets of isolates 
(isolates 8-1 and 2-4; isolate 2-3 and the isolates from pa-
tient 7) exhibited different PFGE and C1 fingerprinting pat-
terns. This result is in contrast to the finding that 2 respira-
tory isolates from the same patient (isolate 2-3 and isolate 
2-4) showed 2 allelic differences (ACC1 and ADP1 genes) 
by MLST, but had very similar PFGE and C1 fingerprinting 
patterns (Fig. 1).
 
DISCUSSION
MLST allows the exchange of genotyping data via the in-
ternet for global epidemiology [7, 8]. A large amount of 
MLST data of C. albicans has accumulated from diverse lo-
cations, and it has been analyzed on a website. To date, an 
MLST study of C. albicans isolates has not been performed 
in Korea. The present study showed that some C. albicans 
strains that cause candidemia at our hospital shared the 
same MLST type with strains from other geographic re-
gions of the world. Overall, 22 isolates from 12 patients be-
longed to new sequence types (10 DSTs), whereas 23 iso-
lates from 14 patients belonged to previously described 
types (10 DSTs). In this study, 4 polymorphic nucleotide 
sites were identified. Our study showed that MLST allows 
an exchange of international genotyping data and offers dis-
tinctive standardization and portability.110     www.kjlm.org
Myoung Y, et al.  •  MLST for Candida albicans
DOI 10.3343/kjlm.2011.31.2.107
KJLM
Table 1. Positions of polymorphic nucleotide sites, associated amino acid changes, and allele number at the 7 loci used for multilocus sequence typing analysis
Fragment Allele number* N of isolates Nucleotide position
†
  AAT1a
1
2
3
5
6
11
21
25
55
70
7
2
1
2
1
2
10
3
7
3
7
A
R
G
·
R
·
·
·
·
·
28
T
·
·
·
·
·
·
Y
C
Y
40
R 
·
A
·
A
·
A
G
G
G
70
T 
·
·
·
·
Y
Y
·
·
·
89
A
R
·
R
·
R
·
·
·
R
124
Y
·
C
·
C
·
C
T
·
T
325
Y
C
C
C
C
C
C
C
·
·
Amino acid changes 1/V ·
  ACC1
3
7
14
17
26
32
46
47
78
82
‡
2
14
9
4
2
4
1
1
2
1
8
G
·
·
·
·
R
·
·
·
R
119
G
·
·
·
·
·
R
A
·
·
164
C
·
·
·
·
·
·
·
Y
·
211
A
·
·
M
·
·
·
·
M
·
281
C
T
Y
·
·
·
Y
·
·
·
317
C
·
·
T
Y
·
·
·
Y
Y
392
C
·
·
·
·
Y
·
·
·
·
Amino acid changes K
§/T
  ADP1
4
5
6
8
10
15
21
104
‡
6
2
8
3
4
6
8
1
35
A
R
·
·
·
·
·
·
40
C
·
·
·
T
Y
Y
T
46
C
·
·
·
T
Y
Y
T
109
A
·
·
·
G
R
R
G
125
R
A
A
A
G
G
·
G
166
G
·
·
·
A
R
R
A
205
G
·
·
·
A
R
R
A
215
G
·
·
R
·
·
·
·
225
T
·
·
·
A
W
W
A
232
C
·
·
·
T
Y
Y
T
282 
G
·
·
·
·
·
·
C
Amino acid changes E/K I/V A/T A/T I/V L/Q E/Q A/G
  MPIb 3
4
5
6
9
14
19
34
50
54
9
10
1
6
2
1
4
2
2
1
21
G
A
·
·
·
·
·
·
·
27
A
G
G
G
·
·
G
R
G
·
34
G
A
A
A
·
·
A
R
A
·
36
T
C
C
C
·
·
C
Y
C
·
66
T
G
G
G
·
·
G
K
G
·
72
A
T
T
T
·
·
T
W
T
·
88
R
G
G
G
A
G
G
G
G
·
107
C
·
·
·
·
· 
·
·
M
·
225
A
·
·
·
·
·
·
·
·
M
234
C
·
·
M
·
·
A
M
·
·
237
A
·
·
R
·
·
G
R
·
·
276
G
·
·
R
·
·
A
R
·
·
289
A
·
·
R
·
·
G
R
·
·
Amino acid changes A/T D/E I/V P/Q D/E D/E G/R G/R G/R
(Continued to the next page)Myoung Y, et al.  •  MLST for Candida albicans
www.kjlm.org     111 DOI 10.3343/kjlm.2011.31.2.107
KJLM
Table 1. (Continued from the previous page) Positions of polymorphic nucleotide sites, associated amino acid changes, and allele number at the 7 loci used for 
multilocus sequence typing analysis
Fragment Allele number* N of isolates Nucleotide position
†
  SYA1
2
6
7
27
34
53
61
75
162
‡
163
‡
3
9
5
4
7
2
1
1
5
1
1
T
Y
·
·
·
·
Y
·
Y
C
25
A
C
M
M
C
C
C
C
C
C
61
G
R
R
A
A
A
R
R
A
·
100
C
T
Y
T
T
T
T
T
·
T
142
A
G
R
G
G
G
G
G
·
G
160
T
C
Y
C
C
C
C
C
Y
C
185
G
·
·
·
·
·
·
·
K
·
307
C
·
·
A
·
A
·
·
·
A
351
C
T
Y
·
T
·
Y
T
·
Amino acid changes A/S A/V
  VPS13 6
10
27
45
60
74
83
105
109
113
2
3
3
9
2
2
4
7
1
5
49
C
·
·
·
·
·
M
·
·
M
134
A
W
·
·
W
W
W
·
·
·
211
G
·
·
·
·
·
·
·
·
R
217
Y
T
·
T
T
T
T
·
T
T
241
A
·
·
·
·
R
·
R
·
·
281
R
A
·
A
A
·
·
G
A
G
282
G
·
·
·
·
R
·
R
·
·
320
G
·
·
·
·
·
R
·
·
R
322
K
T
·
G
·
T
T
T
·
T
326
G
·
·
·
·
·
·
·
R
·
370
W
T
·
T
T
T
·
·
T
A
375
Y
C
C
C
·
C
C
C
C
C
Amino acid changes C/S E/G/K/R E/G/K/R I/V M/V K/N F/S
  ZWF1b
5
8
12
13
15
22
37
112
119
2
3
8
2
7
5
3
6
2
23
A
M
·
·
M
C
M
M
M
31
Y
C
T
·
·
C
C
C
C
43
W
·
T
·
T
T
·
·
·
49
T
C
·
Y
Y
C
Y
C
C
55
T
C
·
Y
Y
C
C
C
C
62
G
·
·
·
·
·
·
·
R
274
A
·
·
·
·
·
R
R
· 
337
Y
C
T
·
·
C
·
C
C
379
Y
T
T
T
T
T
T
T
T
482
W
A
A
A
A
A
A
A
A
Amino acid changes K/Q A/T F/I
*Allele numbers are based on those in the MLST database (http:// test1.mlst.net); 
†One letter IUPAC nucleotide code: R=A or G; M=A or C; W=A or T; Y=C or T; K=G or T; S=C 
or G; 
‡Indicates new (unpublished) genotypes identified in this study; 
§Single letter amino acid symbols.
Chen et al. [8] reported that MLST is superior to REAG-B 
for tracing the microevolution of C. albicans strains within 
the same patient. However, simultaneous comparison of 
MLST, REAG-B, REAG-S, and C1 fingerprinting techniques 
for the detection of microevolution of C. albicans strains 
from patients with BSI has not been performed. In this 
study, multiple isolates from the same patient showing dif-
ferent DSTs were examined. By MLST, 1 or 2 allelic differ-
ences, indicative of microevolution [7], were found in 6 sets 
of isolates. REAG-B, REAG-S, and C1 fingerprinting also 
detected microevolution among 5, 2, and 5 sets of isolates 
from the same patient. However, none of these 4 methods 
detected all 7 sets of microevolution that were detected by 
combining all 4 methods used in this study. These results 
show that MLST is as efficient as C1 fingerprinting and 
REAG for detecting microevolution among sequential C. 
albicans isolates from Candida BSI.
Two previous studies showed that MLST analysis has the 
highest levels of concordance with Ca3 Southern hybridiza-
tion [10] and REAG-B in discriminating epidemiologically 
related strains [8]. We analyzed 2 previously recognized 
nosocomial clusters of BSI that had been evaluated by PFGE 
and C1 fingerprinting techniques with MLST. MLST analy-
sis clearly identified 9 patients’ isolates from 2 nosocomial 112     www.kjlm.org
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Table 2. Genotyping results for Candida albicans from blood and other body sites from 21 patients with candidemia
Patient Isolate
No.
Isolation
interval 
(days)*
Source
PFGE
†
C1 
fingerprinting
†
MLST allele number for a given loci
MLST 
DST Karyot
yping REAG-B REAG-S AAT1a ACC1 ADP1 MPIb SYA1 VPS13 ZWF1b
  1 1-1
1-2
-9 CVC
e
Blood
K1
K1
B1a
B1b
S1
S1
C1
C1
21
21
17
17
21
21
19
19
53
53
83
83
22
22
1,646
1,646
  2 2-1
2-2
2-3
2-4
2-5
2-6
2-7
-5
0
1
14
18
32
CVC
Blood
Respiratory
Respiratory
Blood
Blood
CVC
K2
K2
K3
K3
K2
K2
K2
B2a
B2b
B3
B3
B2a
B2a
B2a
S2
S2
S3a
S3b
S2
S2
S2
C2a
C2b
C3a
C3b
C2b
C2b
C2b
21
21
55
55
21
21
21
46
7
7
14
7
7
7
21
10
6
4
10
10
10
4
4
3
3
4
4
4
162
162
6
6
162
162
162
113
113
45
45
113
113
113
12
12
15
15
12
12
12
1,788
‡
1,797
‡
1,791
‡
365
1,797
‡
1,797
‡
1,797
‡
  3 3-1
3-2 0
Blood
CVC
K4
K4
B4
B4
S4
S4
C4
C4
2
2
78
78
5
5
9
9
2
2
6
6
5
5
1,395
1,395
  4 4-1
4-2
4-3
+1
+3
Blood
Blood
CVC
K5
K5
K5
B5
B5
B5
S5
S5
S5
C5
C5
C5
70
70
70
14
14
14
8
8
8
4
4
4
7
7
7
10
10
10
8
8
8
656
656
656
  5 5-1
5-2 -7
Blood
Urine
K6
K6
B6
B6
S6
S6
C6
C6
11
11
26
26
6
6
4
4
34
34
60
60
119
119
659
659
  6 6-1
6-2 -4
Blood
Respiratory
K7
K7
B7
B7
S7
S7
C7a
C7b
21
21
17
17
6
21
19
19
27
27
83
83
22
22
1,794
‡
601
  7 7-1
7-2
7-3
7-4
0
+9
+9
Blood
Liver
Peritoneum
Kidney
K8
K8
K8
K8
B8
B8
B8
B8
S3a
S3a
S3a
S3a
C8a
C8a
C8a
C8a
55
55
55
55
14
14
14
14
4
4
4
4
3
3
3
3
6
6
6
6
45
45
45
45
15
15
15
15
365
365
365
365
  8 8-1 Blood K9 B9 S3a C8b 55 14 4 54 6 45 15 602
  9 9-1
9-2
9-3
0
0
Blood
CVC
CVC
K1
K1
K1
B10a
B10a
B10b
S8
S8
S8
C9a
C9a
C9b
25
25
25
7
7
7
6
6
6
3
3
3
6
6
75
27
27
27
37
37
37
90
90
1,795
‡
10 10-1 Blood K10 B11 S9 C10 21 82 6 14 163 105 12 1,789
‡
11 11-1
11-2
11-3
11-4
11-5
11-6
-8
-7
-7
-4
+3
Respiratory
Respiratory
Respiratory
Urine
Blood
Blood
K11
K11
K11
K11
K11
K11
B12a
B12b
B12b
B12b
B12b
B12b
S10a
S10b
S10b
S10b
S10b
S10b
C11
C11
C11
C11
C11
C11
1
1
1
1
1
1
7
7
7
7
7
7
15
15
15
15
15
15
6
6
6
6
6
6
61
34
34
34
34
34
105
105
105
105
105
105
112
112
112
112
112
112
693
1,796
‡
1,796
‡
1,796
‡
1,796
‡
1,796
‡
12 12-1 Blood K5 B13 S11 C12 1 47 104 5 2 109 22 1,790
‡
13 13-1 Blood K10 B14 S12 C13 5 32 21 34 7 74 12 1,792
‡
14 14-1 Blood K10 B14 S12 C13 5 32 21 34 7 74 12 1,792
‡
15 15-1 Blood K10 B14 S12 C13 5 32 21 34 7 74 12 1,792
‡
16 16-1
16-2 +6
Blood
CVC
K10
K10
B14
B14
S12
S12
C13
C13
5
5
32
32
21
21
34
34
7
7
74
74
12
12
1,792
‡
1,792
‡
17 17-1 Blood K10 B14 S12 C13 5 32 21 34 7 74 12 1,792
‡
18 18-1
18-2 +3
Blood
CVC
K12
K12
B15a
B15b
S13a
S13b
C14a
C14b
6
3
3
3
21
21
50
50
27
27
45
45
13
13
1,711
1,793
‡
19 19-1 Blood K12 B15a S13a C14a 6 3 21 50 27 45 13 1,711
20 20-1 Blood K12 B15a S13a C14a 6 3 21 50 27 45 13 1,711
21 21-1 Blood K12 B15a S13a C14a 6 3 21 50 27 45 13 1,711
*Interval between the isolation of C. albicans from a blood culture and other body sites in each patient, which is presented as the number of days before (-) or after (+) the first 
positive blood culture; 
†The differences denoted, a or b, are insufficient to classify the isolate as different rather than similar (sharing all of the bands except 1 or 2 bands); 
‡Indicates 
new (unpublished) diploid sequence types identified in this study.
Abbreviations: PFGE, pulsed-field gel electrophoresis; REAG, restriction endonuclease analysis of genomic DNA; MLST, multilocus sequence typing; DST, diploid sequence type; CVC, 
central venous catheter.Myoung Y, et al.  •  MLST for Candida albicans
www.kjlm.org     113 DOI 10.3343/kjlm.2011.31.2.107
KJLM
clusters as 2 DSTs (DSTs 1711 and 1792). Of these 9 patient 
isolates, 1 catheter isolate from patient 18 showed a different 
DST (DST 1793) from corresponding blood isolates (DST 
1711); however, it differed by only 1 locus, suggesting mi-
croevolution. This finding, together with microevolution 
observed among serial isolates from the same patient, sug-
gest that closely related C. albicans strains, which have dif-
ferent DSTs only at 1 or 2 of the sequenced alleles, may be 
classified as epidemiologically related strains.
Of particular note in our study is that 1 set of isolates 
classified as the same DST (DST 365) by MLST differed in 
PFGE and C1 fingerprinting patterns. In addition, 3 sets of 
isolates from different patients in whom MLST showed 1 or 
2 allelic differences (closely related), also revealed different 
patterns by PFGE or C1 fingerprinting. These isolates from 
4 sets, which showed the same or similar MLST but exhib-
ited different PFGE or C1 fingerprinting patterns,  were ob-
tained from 3 epidemiologically unrelated patients. These 
results suggest that MLST may be less useful for long-term 
epidemiological surveillance of C. albicans isolates in a hos-
pital setting, and that REAG-B perhaps constitutes the more 
useful method for confirming MLST findings. In addition, 
our data show that MLST analysis of C. albicans isolates, in 
the absence of epidemiologic data, may not be recom-
mended as a routine component of infection control, but 
that it may be useful in evaluating putative outbreaks iden-
tified by conventional hospital surveillance.
Odds et al. [11] also noted a few examples among their 
isolates that were very closely related according to MLST 
analysis, but that differed in ABC type, which is a very stable 
epidemiological marker in C. albicans isolates. Our results, 
together with those by Odds et al. [11], highlight the limita-
tion of the MLST analysis in typing diverse strains of C. al-
bicans from different patients (inter-patient analysis). These 
data suggest that frequent genetic evolutionary changes in C. 
albicans isolates may affect the interpretation of MLST data, 
especially for detecting inter- and intra-hospital spread of C. 
albicans strains. Therefore, the C. albicans strains at our hos-
pital that shared the same DST with strains from other geo-
graphic regions of the world need further characterizing by 
PFGE or C1 fingerprinting.
In summary, we compared MLST, PFGE, and C1 finger-
printing for typing C. albicans isolates from patients with 
BSI. The results show that although MLST is a powerful tool 
for discriminating and detecting microevolution among C. 
albicans isolates, it has some limitations in typing diverse 
Fig. 1. Representative genotyping patterns of Candida albicans obtained by Southern hybridization with the C1 fragment of the Ca3 probe (C1 fingerprinting), 
electrophoretic karyotyping (EK), and restriction endonuclease analysis of genomic DNA using SfiI (REAG-S) and BssHII (REAG-B). See Table 2 for detailed informa-
tion on each isolate from 8 patients (patients 1–8). All sequential isolates had the same karyotype and showed the same or similar REAG and C1 fingerprinting 
patterns, except for 2 isolates (2-3 and 2-4) from patient 2. Stars indicate the positions of added or deleted bands in the minor patterns for clonal strains from the 
same patient, suggesting that microevolution had occurred. Three sets of isolates from different patients (isolates 7-1 and 8-1; isolates 8-1 and 2-4; isolates 7-1 
and 2-3), which differed in only 1 or 2 alleles according to MLST analysis, revealed different PFGE or C1 fingerprinting patterns.
Abbreviations: A, C. albicans ATCC 90028; M, Saccharomyces cerevisiae DNA concatamers as a molecular size marker.
C1 fingerprinting
EK
REAG-B
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strains of C. albicans from different patients. Therefore, we 
suggest that REAG or C1 fingerprinting can be a very help-
ful confirmatory tool in instances when C. albicans isolates 
from different patients show the same or similar (differ by 
only 1 or 2 alleles) MLST types.
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